Lufthansa Cargo has secured renewal of its IATA CEIV Pharma certification, extending the accreditation through April 2029 and reaffirming its commitment to high standards in pharmaceutical logistics handling.
The certification, awarded by the International Air Transport Association under its Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) programme, recognises compliance with stringent global requirements for the transportation and handling of temperature-sensitive pharmaceutical products.
Lufthansa Cargo said the renewed accreditation reflects its continued focus on maintaining quality, safety and reliability across its pharma supply chain operations. The airline operates specialised temperature-controlled infrastructure and handling processes designed to support the safe movement of vaccines, biopharmaceuticals and other healthcare products worldwide.
The carrier has invested in dedicated pharma hubs, digital monitoring systems and trained personnel to ensure compliance with international healthcare logistics standards. Industry analysts noted that demand for certified pharmaceutical air cargo services continues to rise amid growth in global healthcare trade and biologics shipments.
The CEIV Pharma programme is aimed at improving consistency and transparency in pharmaceutical airfreight operations by establishing globally harmonised handling standards across the supply chain. Lufthansa Cargo said the renewed certification strengthens customer confidence and supports its position in the growing healthcare logistics market.